Novis S A, De Mattos J P, De Rosso A L
Servico de Neurologia do Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro, Brasil.
Arq Neuropsiquiatr. 1995 Sep;53(3-A):403-10.
The effects of botulinum toxin type A were studied in 33 patients with dystonia (12 blepharospasms, 10 hemifacial spasms and 11 spasmodic torticollis). A rate scale was used to evaluate the severity of the dystonic movements, before and two weeks after each injection. Among blepharospasm patients, eight were female and four were male; the mean age was 57.7 years; the mean time of the disease duration was four years. Three had familial history for similar disease; nine were essential and three had used neuroleptic drugs (tardive dystonia). The mean dose used was 51.3 U, with a mean time of beneficial effects of 2.8 months. For 22 injections and reinjections, 14 (63.7%) showed an excellent result, five (22.7%) good and three (13.6%) null. In the hemifacial spasm group, eight were female and two male; the mean age was 52.6 years; the mean time of the disease duration was 7.4 years; eight were essential and two post-paralytic. The mean dose used was 32 U. From the total of 15 injections and reinjections, all of them (100%) had an excellent result, with a mean time of beneficial effect of 3.4 months. Among the cervical dystonic patients, eight were male and three female; the mean age was 44.2 years; the mean time of the disease duration was 12.2 years; six had essential dystonia, three had used neuroleptic drugs and two had familial history for similar disease. The mean dose used was 238.6 U, with the mean duration of effect of 3.5 months. From the total of 20 injections and reinjections, 18 (90%) had good result, one (5%) mild and one (5%) null.(ABSTRACT TRUNCATED AT 250 WORDS)
对33例肌张力障碍患者(12例眼睑痉挛、10例偏侧面肌痉挛和11例痉挛性斜颈)进行了A型肉毒毒素效果的研究。采用评分量表在每次注射前及注射后两周评估肌张力障碍性运动的严重程度。眼睑痉挛患者中,女性8例,男性4例;平均年龄57.7岁;平均病程4年。3例有类似疾病家族史;9例为原发性,3例曾使用抗精神病药物(迟发性肌张力障碍)。平均使用剂量为51.3单位,平均有益作用时间为2.8个月。在22次注射和再次注射中,14例(63.7%)效果极佳,5例(22.7%)良好,3例(13.6%)无效。在偏侧面肌痉挛组中,女性8例,男性2例;平均年龄52.6岁;平均病程7.4年;8例为原发性,2例为麻痹后型。平均使用剂量为32单位。在总共15次注射和再次注射中,所有患者(100%)效果极佳,平均有益作用时间为3.4个月。在颈部肌张力障碍患者中,男性8例,女性3例;平均年龄44.2岁;平均病程12.2年;6例为原发性肌张力障碍,3例曾使用抗精神病药物,2例有类似疾病家族史。平均使用剂量为238.6单位,平均作用持续时间为3.5个月。在总共20次注射和再次注射中,18例(90%)效果良好,1例(5%)效果轻微,1例(5%)无效。(摘要截短至250字)